PRF1 and neoplasm: Importantly, the combination therapy markedly increased the population of granzyme+perforin+CD8+ T cells, IFN-γ+ TNF-α+CD8+ T cells, Ki67 +CD8+ T cells, and CD4+ T cells in the tumor region (figure 5G,H, onlinesupplemental figure 11A, B).